Mirvaso Gel

Mirvaso is a topical treatment for rosacea that contains brimonidine tartrate. This is known as an alpha agonist and can reduce the redness and flushed demeanour that people experience due to rosacea.

The active ingredient, brimonidine, is present at a concentration of 0.33% and can effectively minimise vasodilation, which is the widening of blood vessels in the face which might promote skin flushing and provocation of rosacea. Application of brimonidine results in less blood flow and reduces the red complexion associated with the condition.

Mirvaso gel is predominantly prescribed to treat redness of facial skin caused by the chronic condition rosacea.

Rosacea leads to inflammation of the nose, cheeks, forehead and chin in adults. It can also lead to the growth of bumps, known as papules, which can become filled with pus (pustules).

The medication is topical, meaning it should be applied and used on the skin only. The medication reduces the redness of skin affected by constricting the blood vessels in the face. This leads to a reduced amount of blood flow to the area, lowering the intensity of flushing.

The active ingredient in Mirvaso gel, brimonidine tartrate, belongs to a class of pharmaceuticals called alpha agonists. This stimulates alpha receptors found in muscle tissues around capillaries and blood vessels just below the surface of the skin.

Rosacea is characterised by redness, flushing and spots. The redness stems from an increased blood flow to the skin on the face. This is due to excessive dilation of the blood vessels in the affected areas.

When the alpha receptors are stimulated by brimonidine tartrate, muscles around these capillaries contract. This causes the blood vessels in the face to constrict, reducing blood flow and redness.

Mirvaso gel is safe and is clinically approved for the topical treatment of rosacea.

Randomised studies have demonstrated the medication is safe to be used once per day over the course of four weeks. Additionally, a more long-term study indicated the medication is safe and effective when it is used for 52 weeks.

Rhofade is another medication that may be prescribed to treat rosacea. While they are both used for a similar purpose, Rhofade contains oxymetazoline as the active ingredient rather than brimonidine tartrate.

There haven’t been any clinical studies directly comparing the efficacy of Rhofade and Mirvaso, though individual studies have shown them both to be effective at treating the symptoms of rosacea.

They also have some similar side effects. For example, both medications can cause the skin to dry out, swell or become flushed. There is also a slim chance that a patient could have an allergic reaction to either of these treatments although this is considered rare.

The majority of people experience positive results when they use Mirvaso gel to treat the redness and flushing caused by rosacea.

People report that the treatment can reduce the redness of their faces relatively quickly, with many experiencing results in a matter of days. As such, if you primarily experience redness as the main symptom of rosacea, Mirvaso gel is an effective treatment option for you.

Mirvaso gel is a prescription only medication and as such it is not available over the counter.

You will need to consult with a medical professional before treating rosacea with the gel. At Cloud Pharmacy, our team of trained pharmacists make this process possible online. Following a short consultation with one of our specialists, you’ll be able to buy Mirvaso gel online. We’ll then dispatch your treatment in discreet packaging which will arrive with you the very next day (for all orders placed before 3pm).